UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 101 filers reported holding UNIQURE NV in Q3 2018. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411,719 | -89.2% | 61,359 | -81.5% | 0.00% | -90.0% |
| Q2 2023 | $3,797,638 | -27.5% | 331,382 | +27.3% | 0.01% | -33.3% |
| Q1 2023 | $5,241,536 | -13.2% | 260,255 | -2.3% | 0.02% | -21.1% |
| Q4 2022 | $6,037,973 | +338.5% | 266,342 | +262.9% | 0.02% | +280.0% |
| Q3 2022 | $1,377,000 | -54.6% | 73,398 | -22.6% | 0.01% | -28.6% |
| Q3 2021 | $3,036,000 | -43.0% | 94,855 | -40.0% | 0.01% | -50.0% |
| Q1 2021 | $5,326,000 | +122.8% | 158,096 | +138.9% | 0.01% | +100.0% |
| Q4 2020 | $2,391,000 | -47.7% | 66,166 | -46.7% | 0.01% | -56.2% |
| Q3 2020 | $4,572,000 | +121.9% | 124,138 | +331.9% | 0.02% | +166.7% |
| Q4 2019 | $2,060,000 | -87.9% | 28,745 | -93.3% | 0.01% | -89.5% |
| Q3 2019 | $16,959,000 | +2579.1% | 430,879 | +5219.5% | 0.06% | +2750.0% |
| Q2 2019 | $633,000 | -80.8% | 8,100 | -85.3% | 0.00% | -81.8% |
| Q1 2019 | $3,291,000 | +644.6% | 55,180 | +260.1% | 0.01% | +450.0% |
| Q4 2018 | $442,000 | +99.1% | 15,322 | +151.6% | 0.00% | +100.0% |
| Q3 2018 | $222,000 | -91.8% | 6,091 | -95.6% | 0.00% | -88.9% |
| Q4 2017 | $2,721,000 | – | 138,891 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |